Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta
- PMID: 12065620
- DOI: 10.1046/j.1471-4159.2002.00918.x
Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta
Abstract
Glycogen synthase kinase 3 (GSK3) plays important roles in Wnt and insulin signaling, cell fate determination, and Alzheimer-like tau phosphorylation. We discovered an isoform of tau protein kinase I (TPKI)/GSK3beta with a 13 amino acid insert in the catalytic domain owing to alternative splicing. The alternative transcripts were found in the brains of the mouse, rat and human, with highly conserved sequences. The variant protein, named TPKI2/GSK3beta2, was abundant in the brain. Immunohistochemistry indicated differential distribution of the conventional and the new TPKI/GSK3beta isoforms within young neurons. TPKI2/GSK3beta2 showed decreased kinase activities towards two phosphorylation sites on tau compared with the conventional isoform. Immunohistochemistry indicated that TPKI2/GSK3beta2 occurs predominantly in the neuronal soma, while TPKI1/GSK3beta1 is found both in the soma and processes. These results indicate that the new splice isoform has a different function. Because the amino acid insert occurs in the domain implicated in interaction with a protein phosphatase in a homologous kinase cdk-2, the alternative splicing can regulate multiprotein complex formation and function involving TPKI/GSK3beta.
Similar articles
-
Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain.J Neurochem. 1994 Jul;63(1):245-55. doi: 10.1046/j.1471-4159.1994.63010245.x. J Neurochem. 1994. PMID: 7515946
-
Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain.J Neurochem. 2010 Nov;115(4):974-83. doi: 10.1111/j.1471-4159.2010.06988.x. Epub 2010 Oct 5. J Neurochem. 2010. PMID: 20831597
-
Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain.Brain Res. 2000 Feb 28;857(1-2):193-206. doi: 10.1016/s0006-8993(99)02424-5. Brain Res. 2000. PMID: 10700568
-
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review.
-
GSK3, a master switch regulating cell-fate specification and tumorigenesis.Curr Opin Genet Dev. 2000 Oct;10(5):508-14. doi: 10.1016/s0959-437x(00)00120-9. Curr Opin Genet Dev. 2000. PMID: 10980428 Review.
Cited by
-
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease.Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8. Mol Neurobiol. 2024. PMID: 38064104 Review.
-
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target.Cells. 2022 Sep 16;11(18):2898. doi: 10.3390/cells11182898. Cells. 2022. PMID: 36139472 Free PMC article. Review.
-
Glycogen Synthase Kinase-3 Isoform Variants and Their Inhibitory Phosphorylation in Human Testes and Spermatozoa.World J Mens Health. 2023 Jan;41(1):215-226. doi: 10.5534/wjmh.220108. Epub 2022 Aug 16. World J Mens Health. 2023. PMID: 36047078 Free PMC article.
-
Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in Ldlr-/- Mice.Int J Mol Sci. 2022 Aug 18;23(16):9293. doi: 10.3390/ijms23169293. Int J Mol Sci. 2022. PMID: 36012557 Free PMC article.
-
GSK-3β Inhibition in Birds Affects Social Behavior and Increases Motor Activity.Front Physiol. 2022 Apr 28;13:881174. doi: 10.3389/fphys.2022.881174. eCollection 2022. Front Physiol. 2022. PMID: 35574473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
